Results 31 to 40 of about 242,337 (233)

Freeze-Dried Softisan® 649-Based Lipid Nanoparticles for Enhanced Skin Delivery of Cyclosporine A

open access: yesNanomaterials, 2020
Inflammatory skin diseases, including psoriasis and atopic dermatitis, affect around one quarter to one third of the world population. Systemic cyclosporine A, an immunosuppressant agent, is included in the current therapeutic armamentarium of these ...
Maria Inês Silva   +5 more
doaj   +1 more source

Topical cyclosporin A in the management of vernal keratoconjunctivitis [PDF]

open access: yesEye, 2001
To study the efficacy of topical cyclosporin A in children with vernal keratoconjunctivitis in a prospective randomised double-masked trial.Twenty-four children between 5 and 16 years of age were randomly treated with cyclosporin A (CsA) and placebo (vehicle) and followed up for 4 months.Of the 12 patients given CsA, 11 showed symptomatic improvement ...
V, Gupta, P K, Sahu
openaire   +2 more sources

Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis

open access: yesDermatologic Therapy, 2022
Nail psoriasis is a chronic nail disorder that commonly affects psoriatic patients causing severe distress despite the limited body surface area. Treatments for nail psoriasis are limited, as nails are often difficult to treat with topical therapies, and
Giuseppe Gallo   +7 more
doaj   +1 more source

Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)

open access: yes, 2013
PURPOSE. Evaluation of the use of topical cyclosporine eyedrops in the treatment of severe dry eye disease in liver transplanted patients with familial amyloidotic polyneuropathy (FAP) unresponsive to therapy with artificial tears and lacrimal plugs ...
Beirão, I.B.   +4 more
core   +1 more source

Bilateral microsporidial keratoconjunctivitis in a clinically healthy female receiving intravitreal steroid injections: Associations and potential risk factors

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To present a unique case of bilateral microsporidial keratoconjunctivitis in a clinically healthy female receiving intravitreal steroid injections, and explore several associations and potential risk factors.
Timothy Y. Chou   +4 more
doaj   +1 more source

Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis - A long-term follow-up

open access: yes, 2008
Purpose: To report the efficacy of topical cyclosporine A (CsA) 0.05% drops (Restasis; Allergan, Irvine, CA) in the treatment of superior limbic keratoconjunctivitis (SLK)
Bozkurt, Banu   +2 more
core   +1 more source

Reply to Comment on: 'Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine'

open access: yes, 2017
Reply to Comment on: ‘Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical ...
Cillino S.   +31 more
core   +1 more source

Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin

open access: yesMolecules, 2020
Psoriasis is one of the most common human skin disorders. Although its pathogenesis is complex and not completely know, the hyperactivation of the immune system seem to have a key role.
Sonia Trombino   +5 more
doaj   +1 more source

Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence

open access: yes, 2019
Purpose: We evaluated the role of the conjunctival flap rotation technique using 5-fluorouracil and adjuvant therapy with topical cyclosporine A at 0.05% during short pre- and postoperative periods for the prevention of primary pterygium recurrence ...
Roberta Lilian Fernandes de Sousa Meneghim (6047741)   +6 more
core   +2 more sources

Self‐Propelled HPB@Lip@AB Nanomotors Ameliorate Dry Eye Disease

open access: yesAdvanced Science, EarlyView.
A self‐propelled HPB@Lip@AB nanomotor system is developed for dry eye disease (DED) therapy, facilitating rapid penetration across ocular surface barriers while integrating hydrogen therapy with multi‐enzyme‐like antioxidant activity. The nanoplatform restores mitochondrial function, suppresses oxidative stress, inflammation, and apoptosis, and ...
Jing Li   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy